FDA panel recommends longer diabetic drug studies

Posted by Amanda Lents

An Federal Drug and Food Administration Advisory Panel says companies should conduct long-term studies on the heart risks associated with diabetes drugs before they are approved.

Currently companies need to show their drug can control blood sugar in order to get approval.

However, last year a study found the diabetes drug Avandia helped blood sugar levels but possibly increased a patient's risk for heart disease.

The advisory panel said studies looking at heart risks and benefits should start before a drug is approved.

The FDA does not need to follow the panel's recommendation, but they usually do.